Clinical trials
Hyperlipidemias trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 7 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 6 |
| Novartis Pharmaceuticals | 4 |
| Pfizer | 4 |
| AstraZeneca | 2 |
| Instituto de Ciencia y Tecnología de Alimentos y Nutrición | 2 |
| 89bio, Inc. | 1 |
| Bayer | 1 |
| Federico II University | 1 |
| Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 1 |
| Instituto de Investigación Hospital Universitario La Paz | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 32 |
| Hypercholesterolemia | 13 |
| Hypertension | 6 |
| Cardiovascular Diseases | 5 |
| Dyslipidemias | 5 |
| Inflammation | 4 |
| Diabetes Mellitus | 3 |
| Hypertriglyceridemia | 3 |
| Metabolic Syndrome | 3 |
| Myocardial Infarction | 3 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.